Patent ID: 9512223
Filing Date: 2016-12-06
CPC Classification: A61K,A61P,C07K,G01N

Claim Text:
1. A method for treating folate receptor-alpha-expressing gastric cancer in a subject in need thereof comprising administering to said subject a therapeutically effective amount of an antibody that specifically binds folate receptor alpha, wherein said antibody comprises a heavy chain CDR1 (CDRH1) comprising the amino acid sequence of SEQ ID NO: 1; CDR2 (CDRH2) comprising the amino acid sequence of SEQ ID NO: 2; and CDR3 (CDRH3) the amino acid sequence of comprising SEQ ID NO: 3, and light chain CDR1 (CDRL1) comprising the amino acid sequence of SEQ ID NO: 4; light chain CDR2 (CDRL2) comprising the amino acid sequence of SEQ ID NO: 5; and CDR3 (CDRL3) comprising the amino acid sequence of SEQ ID NO:6, or an antigen-binding fragment thereof.